Hasil Pencarian (1)
biotech | CAS: 1428935-60-7
Durvalumab is a human immunoglobulin G1 kappa (IgG1?) monoclonal antibody and a novel immune-checkpoint inhibitor for cancer treatment.[A192789] Produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture,[L12621] durvalumab …
Kategori:
Amino Acids, Peptides, and ProteinsAntibiotics, AntineoplasticAntibodies
+20
Target Protein:
Programmed cell death 1 ligand 1Programmed cell death protein 1
Waktu ParuhBased on baseline c…
Vol. DistribusiIn patients receivi…
KlirensClearance of durval…
Genetik
-